Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy

• Ahmed El-Shamy,

  Affiliations Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan, Department of Virology, Suez Canal University Faculty of Veterinary Medicine, Ismalia, Egypt

  ⨯
• Ikuo Shoji,

  Affiliation Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Soo-Ryang Kim,

  Affiliation Division of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan

  ⨯
• Yoshihiro Ide,

  Affiliation Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Susumu Imoto,

  Affiliation Division of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan

  ⨯
• Lin Deng,

  Affiliation Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Seitetsu Yoon,

  Affiliation Department of Gastroenterology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Hyogo, Japan

  ⨯
• Takashi Fujisawa,

  Affiliation Department of Internal Medicine, Nippon Steel Hirohata Hospital, Himeji, Hyogo, Japan

  ⨯
• Satoshi Tani,

  Affiliation Department of Internal Medicine, Konan Hospital, Kobe, Japan

  ⨯
• Yoshihiko Yano,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Yasushi Seo,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Takeshi Azuma,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Hak Hotta

  * E-mail: hotta@kobe-u.ac.jp

  Affiliation Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯